Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohty

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Hematology (Amsterdam, Netherlands)|September 24, 2002
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantationM Mohty, B Gaugler, C Faucher, et al.
Bone Marrow Transplantation|October 3, 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMTJ Loke, M Labopin, C Craddock, et al.
Bone Marrow Transplantation|September 26, 2001
Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapyM Mohty, N Fegueux, C Exbrayat, et al.
Leukemia|February 1, 2012
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMTA Spyridonidis, M Labopin, C Schmid, et al.
Bone Marrow Transplantation|February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Internal Medicine|April 24, 2012
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patientsO Ringdén, M Labopin, D W Beelen, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Hematology (Amsterdam, Netherlands)|September 24, 2002
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantationM Mohty, B Gaugler, C Faucher, et al.
Bone Marrow Transplantation|October 3, 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMTJ Loke, M Labopin, C Craddock, et al.
Bone Marrow Transplantation|September 26, 2001
Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapyM Mohty, N Fegueux, C Exbrayat, et al.
Leukemia|February 1, 2012
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMTA Spyridonidis, M Labopin, C Schmid, et al.
Bone Marrow Transplantation|February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Internal Medicine|April 24, 2012
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patientsO Ringdén, M Labopin, D W Beelen, et al.
Pageof 18